#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Barth syndrome Thyroid cancer metastatic Paget's disease of the vulva Giant cell tumour of tendon sheath Adenocarcinoma pancreas Osteopetrosis Nephroblastoma Small for dates baby Mitochondrial DNA depletion X-linked lymphoproliferative syndrome Peripheral primitive neuroectodermal tumour of soft tissue Gaucher's disease type I Adrenoleukodystrophy Haemophilia A with anti factor VIII Krabbe's disease More trials…

    Learn about Rare Diseases

    Hairy cell leukaemia recurrent – Diagnostics Malignant fibrous histiocytoma – Diagnostics Usher’s syndrome – Treatment Lysosomal storage disorder – Diagnostics Hairy cell leukaemia Pituitary-dependent Cushing’s syndrome – Life with Disease Andersen-Tawil syndrome – Life with Disease Mantle cell lymphoma stage III – Diagnostics Rhabdoid tumour – Diagnostics Uterine leiomyosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tucatinib Caraway Oil Esmolol Hydrochloride Lymecycline Irinotecan Etravirine Xtmab-16 R2R01 Levofloxacin Imidapril Hydrochloride Tramazoline Hydrochloride ZINC GLUCONATE Ivospemin Human Von Willebrand Factor Avacincaptad Pegol Molidustat Sodium Omp12 Atrasentan Hydrochloride GOVORESTAT Daridorexant More therapies…

    Learn about Your Condition

    Hodgkin's disease recurrent Nephrotic syndrome Triple negative breast cancer Lung transplant Chronic spontaneous urticaria Sexual dysfunction Leiomyosarcoma Athetosis Aortic stenosis Epidermolysis bullosa Meniere's disease Plasma cell myeloma Endolymphatic hydrops Adenocarcinoma of colon Neutropenia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bone marrow disorder

  • Study on the Effectiveness and Safety of Luspatercept for Patients with Lower-Risk Myelodysplastic Syndromes Requiring Red Blood Cell Transfusions

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Bone marrow disorder
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Luspatercept
    Austria Germany Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!